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ABSTRACT
We have developed a new approach to systemati-
cally study post-transcriptional regulation in a small
number of cells. Actively translating mRNAs are
associated with polysomes and the newly
synthesized peptide chains are closely associated
with molecular chaperones such as hsp70s, which
assist in the proper folding of nascent polypeptides
into higher ordered structures. These chaperones
provide an anchor with which to separate actively
translating mRNAs associated with polysomes
from free mRNAs. Affinity capture beads were
developed to capture hsp70 chaperones associated
with the polysome complexes. The isolated actively
translating mRNAs were used for high-throughput
expression profiling analysis. Feasibility was
demonstrated using an in vitro translation system
with known translationally regulated mRNA tran-
script thymidylate synthase (TS). We further
developed the approach using HCT-116 colon
cancer cells with both TS and p53 as positive
controls. The steady-state levels of TS and p53
mRNAs were unaltered after 5-fluorouracil treat-
ment as assessed by real-time qRT-PCR analysis.
In contrast, the protein expression and polysome-
associated mRNA levels of both genes were
increased. These differences in translational rate
were revealed with our new approach from 500
cells. This technology has the potential to make
investigation of translational control feasible with
limited quantities of clinical specimens.
INTRODUCTION
While most investigators have focused on transcriptional
regulation of gene expression in the past, recent studies
indicate that post-transcriptional and, especially,
translational regulation plays a key role during develop-
ment, cell cycle control and drug resistance (1–5).
Particularly with the recent discovery that non-coding
microRNAs are important regulators of translation, it is
important to develop a simple and accurate approach to
investigate genes regulated at the post-transcriptional
and translational levels. We and others have previously
developed approaches to systematically investigate
genes regulated post-transcriptionally by proﬁling trans-
lationally active mRNAs obtained from isolated
polysomes with a high-throughput gene expression
analysis platform (6–8). These approaches allowed us to
analyze mRNA levels at the ﬁnal mRNA translation step
of protein synthesis. However, the limitation of these
approaches is that they all relied on a traditional sucrose
gradient density ultracentrifugation procedure to isolate
polysome complexes, thus requiring many (up to 10
9)
cells. As a result, current polysome isolation techniques
are the major bottleneck for the investigation of
post-transcriptionally regulated genes when one is faced
with limited quantities of clinical specimens (e.g. needle
biopsies of primary and metastatic tumors, isolated
circulating tumor cells). There is thus a critical need to
develop a novel approach to isolate polysome-loaded
mRNAs from very few cells.
The new approach described here stemmed from
previous studies indicating that mRNAs being actively
translated are associated with multiple units of ribosomes
(polyribosomes or polysomes) and the newly synthesized
polypeptides are closely associated with molecular chap-
erones, including members of the hsp70 and hsc70 families
(9–11). Chaperones can assist in the eﬃcient folding of
newly translated proteins as they are being synthesized
on the ribosome and can maintain pre-existing proteins
in a stable conformation to avoid premature folding and
modiﬁcations (12,13). We therefore reasoned that such
chaperones can provide a molecular anchor for separating
polysome-loaded mRNAs from free mRNAs. In this
study, we apply this principle to develop and optimize
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translated mRNAs associated with hsp70 family chaper-
ones. The translationally active mRNAs in the polysome
complex are pelleted by an antibody recognizing the
hsp70/hsc70 chaperone proteins associated with nascent
polypeptides of the complex (Figure 1). Bound RNAs
are then puriﬁed and used for high-throughput expression
proﬁling analysis.
Translational control plays an important role in
chemoresistance, such as acute resistance to 5-ﬂuorouracil
(5-FU) treatment (14–16). Previous studies have identiﬁed
that the target enzyme of 5-FU, thymidylate synthase
(TS), is regulated at the translational level (15). In
addition, as an RNA binding protein, TS not only nega-
tively regulates its own synthesis at the translational level,
but also interacts directly with p53 mRNA to down-
regulate p53 protein expression (17–19). In this study,
we developed a novel approach to isolate translationally
active mRNAs from a small number (500) of colon cancer
HCT-116 cells for gene expression analysis, allowing us to
systematically study mRNAs engaged in nascent transla-
tion during treatment with the chemotherapeutic drug
5-FU. Two previously identiﬁed translationally regulated
genes, p53 and TS, were used as positive controls to
monitor the process. The translationally active
mRNA transcripts were subjected to high-throughput
microarray-based expression proﬁling analysis. Over 500
mRNAs were shown to be diﬀerentially regulated in the
translationally active mRNA fraction after 5-FU treat-
ment. Genes, such as PP2A, a previously known
translationally regulated gene (20), were more abundant
in the polysome complex after treatment, and their
elevated translation levels were conﬁrmed at the protein
level by western immunoblot analysis. Gene Ontology
(GO) analysis revealed that genes in translational
control are involved in some of the important biological
process in response to 5-FU. This novel approach can be
used to study translational control mediated by
RNA-binding proteins and miRNAs when combined
with a parallel expression analysis of steady-state total
mRNAs (21–23).
MATERIALS AND METHODS
Cell culture
The human colon cancer cell line HCT-116 was obtained
from ATCC and maintained at 37C and 5% CO2 in
75-cm
2 plastic tissue culture ﬂasks with McCoy’s 5A
medium containing 10% fetal bovine serum. Cells at
210
5 density were plated in six-well tissue culture
plates for 24h. Cells were then treated with 5mM 5-FU
for 24h; untreated cells were used as controls.
In vitro transcription/translation
Promega’s TnT Quick Coupled rabbit reticulocyte lysate
Transcription/Translation System was utilized to tran-
scribe TS mRNA and subsequently synthesize TS
protein. A plasmid, pGEM-pcHTS-1, containing the
full-length human TS cDNA (1mg), was used as the
template for the in vitro transcription/translation
reaction (15). TS mRNA expression was determined by
real time qRT-PCR analysis and the TS protein was
analyzed using western immunoblot analysis.
Western blot analysis
Equal amounts of protein (25mg) extracted from lysed cell
lines were separated on 10% sodium dodecyl
sulfate-polyacrylamide gels by the method of Laemmli
(24). Proteins were probed with mouse anti-TS
monoclonal antibody (1:5000 dilution) (Zymed
Laboratories, CA, USA), anti-p53 mouse monoclonal
antibody (1:1000) (Santa Cruz Biotech Inc., CA, USA),
anti-a-tubulin (1:1000) (Santa Cruz Biotech Inc., CA,
USA) and anti-PP2A/C (1:1000) (Santa Cruz Biotech
Inc., CA, USA). Horseradish peroxidase-conjugated
antibodies against mouse or rabbit (1:1000, Santa Cruz
Biotechnology) were used as the secondary antibodies.
Protein bands were visualized with a chemiluminescence
detection system using the Super Signal substrate.
Construction of antibody aﬃnity capture beads
We have systematically evaluated three diﬀerent types of
magnetic beads, DynabeadsM-280 Sheep anti-Mouse
IgG, DynabeadsM-280 Sheep anti-Rabbit IgG and
DynabeadsSheep anti-Rat IgG (Invitrogen, Inc). The
required amount of thoroughly suspended beads were
transferred into an Eppendorf tube. Beads were washed
two times with washing buﬀer (PBS with 0.1% BSA, pH
7.4 for DynabeadsM-280 Sheep anti-Mouse IgG and
DynabeadsM-280 Sheep anti-Rabbit IgG and PBS with
0.1% BSA and 2mM EDTA, pH 7.4 for
DynabeadsSheep anti-Rat IgG). Then 1mg/ml target
immunoglobulin was added (a ratio of 1mg/10
7 beads
was found to produce suﬃcient binding). We used three
types of antibodies: HSP70 mouse monoclonal antibody,
HSC70 (HSP73) rabbit polyclonal antibody (Millipore
Inc.) and HSC70 (HSP73) rat monoclonal antibody
(BioVision Inc.). Beads with antibody were incubated
with slow tilt rotation for 24h at 2–8C. The tube was
then placed on a magnet for 2min and supernatant was
removed with a pipette. Antibody-coated beads were
washed three times with washing buﬀer and used for
immunoprecipitation.
Isolation of polysome-associated mRNA transcripts
To prepare cytoplasmic extracts, cells from six-well tissue
culture plates were harvested with 0.05% Trypsin-EDTA
(Invitrogen, CA, USA) and washed with ice-cold PBS con-
taining 100mg/ml cycloheximide (Sigma, MO, USA). Cells
were counted and 10000 cells were incubated with 800ml
of McCoy’s 5A medium containing 10% fetal bovine
serum and 100mg/ml cycloheximide (Sigma, MO, USA)
for 5min at 37C. After incubation, 200ml of DSP
(1mM) (Pierce, IL, USA) was introduced as a
cross-linking reagent and incubation was carried out for
5min at 37C. Excess DSP was quenched with 1M Tris–
HCl (pH 7.4). The cells were washed twice by
centrifugation at 1000r.p.m. for 3min, the supernatant
discarded and the cell pellets were rinsed with ice-cold
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USA). The ﬁnal pellets were swollen for 20min in 500ml
of low salt buﬀer (LSB) (20mM HEPES, pH 7.4, 100mM
KCl, 2mM MgCl2) containing 1mM dithiothreitol and
lysed by the addition of 200ml lysis buﬀer (1LSB con-
taining 1.2% Triton X-100) (Sigma) followed by brief vor-
texing. One-tenth (70ml) of the above lysate was
transferred to the Ig-coated beads, and incubation
carried out for 1–2h at 2–8C.
After incubation with the HSP70/HSP73
antibody-conjugated magnetic beads, the polysome
complexes containing translationally active mRNA tran-
scripts were isolated, and the mRNAs eluted from beads
conjugated with HSP70/HSP73 using the Array Pure
Nanoscale RNA Puriﬁcation Kit (Epicentre, WI, USA).
Quantitative gene expression analysis via real-time
quantitative reverse transcription-polymerase
chain reaction
Real-time quantitative reverse transcription-polymerase
chain reaction (qRT-PCR) analysis was performed on
the control mRNAs. PCR primers and probes (eIF4E,
TS, p53, PP2A) were purchased from Applied
Biosystems (Foster City, CA, USA). qRT-PCR was per-
formed on an ABI 7500HT instrument under the follow-
ing conditions: 25C for 10min and 37C for 30min of
reverse transcription; 95C for 3min, followed by 40 cycles
of 95C for 15s and 60C for 35s (n=3). Signal was
collected at the endpoint of every cycle. The expression
values of genes from diﬀerent samples were calculated
by normalizing with equal RNA input and relative
quantitation values were plotted.
Two-round RNA ampliﬁcation
To systematically discover post-transcriptionally and
translationally regulated genes aﬀected by 5-FU treat-
ment, isolated translationally active mRNAs were used
to proﬁle gene expression using human whole-genome
array analysis. Due to the limited quantities of cellular
RNA isolated from 500 control HCT116 cells and cells
treated with 5-FU, we employed two rounds of RNA
ampliﬁcation using the Agilent Low RNA Input Linear
Ampliﬁcation Kit (Agilent, CA, USA), which was also
used to amplify mRNAs isolated from polysomes. The
T7 promoter primer (1.2ml) was added and the total
reaction volume was adjusted to 11.5ml with nuclease-free
water. The primer and template were incubated at 65C
for 10min and then placed on ice for 5min. cDNA Master
Mix (8.5ml) was added to each sample and incubation
carried out at 40C for 2h, 65C for 15min and on ice
for 5min. Then 60ml of ampliﬁcation reaction buﬀer was
added to 20ml of cDNA product and incubation pro-
ceeded at 40C for 4h. After puriﬁcation, cRNA
products were dried in a Speed Vacuum apparatus and
the total volume adjusted to 10.5ml. Random Hexamers
(1.0ml) were added to the cRNA products, incubation per-
formed at 65C for 10min and the tube chilled to 4C for
5min. To each sample, 9.5ml of cDNA Master Mix sup-
plemented with Cy3-labeled NTPs was added and
incubated at 40C for 2h, 65C for 15min and on ice
for 5min. Then 59ml of ampliﬁcation reaction buﬀer
was added to 21ml of cDNA product and incubation pro-
ceeded at 40C for 4h. The mini elute clean up kits
(Qiagen, CA, USA) were utilized to purify the ampliﬁed
samples after the ﬁrst round ampliﬁcation, and the
RNeasy mini kits (Qiagen, CA, USA) were used to
purify the labeled RNA after the second round in prepa-
ration for expression analysis.
Array hybridization and gene expression analysis
All reagents were provided in the Gene expression
Hybridization Kit (Agilent, CA, USA). Eleven microliters
of 10Blocking Agent and nuclease-free water was added
to 1.65mg of Cy3-labeled linearly ampliﬁed cRNA to bring
the volume to 53ml. Then 2.2mlo f2 5 Fragmentation
buﬀer was added. After vortexing, the RNAs were frag-
mented by incubating at 60C for 30min. To prepare
hybridization mix, 55ml of fragmented cRNA and 55ml
of 2GE Hybridization Buﬀer HI-RPM were mixed
and carefully loaded onto the array gasket well to avoid
bubbles. Hybridization was carried out at 10r.p.m. at
65C for 17h in a hybridization oven. After hybridization,
the arrays were washed with Gene Expression Wash
Buﬀer 1 (Agilent, CA, USA). The slides were then dried
and kept in the dark until scanning. Images were captured
on an Axon GenePix 4200A scanner.
The resulting image was quantiﬁed and the intensity of
each spot divided by the median spot intensity to provide
a scaled and comparable number across multiple arrays.
After dot-grid and quality-control analysis, gene expres-
sion analysis was conducted using GeneSpring software
7.2 (Agilent, CA, USA), which allows multi-ﬁlter compar-
isons using data from diﬀerent experiments to perform the
normalization, generation of restriction lists and func-
tional classiﬁcation of diﬀerentially expressed genes.
Under the Cross-Gene Error Model, normalization was
applied in two steps: (i) ‘per chip normalization’ in
which each measurement was divided by the 50th percen-
tile of all measurements in its array; and (ii) ‘per gene
normalization’ in which all the samples were normalized
against speciﬁc control samples. Then data were ﬁltered
for 4-fold changes. The expression proﬁles of the diﬀer-
ent groups were compared using one-way analysis of
variance (ANOVA) with cut-oﬀ P<0.05. Comparisons
of gene lists across diﬀerent groups were performed
using Venn diagrams and clustering was performed with
the Condition Tree algorithm. The GO groupings and
Gen Maps 2.0 program were used in conjunction with
GeneSpring to identify pathways and functional groups
of genes.
RESULTS
Preparation of antibody aﬃnity capture beads
The principle of our polysome isolation process is
illustrated in Figure 1. Translationally active mRNAs
are associated with multiple units of ribosomes and
the newly synthesized polypeptides are closely asso-
ciated with molecular chaperones, such as hsp70s.
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folding of nascent polypeptides into higher ordered struc-
tures, provide an anchor for separating translationally
active mRNAs associated with polysomes from free
mRNAs. Aﬃnity antibody capture beads will capture
hsp70s chaperones associated with the polysome
complexes so that polysomes can be separated from
monosomes and free mRNAs. The isolated translationally
active mRNAs are used for array based or real-time
qRT-PCR gene expression analysis. To prepare and char-
acterize the aﬃnity capture beads, a number of diﬀerent
hsp70/hsc70 antibodies were evaluated to optimize
the conditions for binding with the polysome complex.
A schematic diagram of the use of these aﬃnity capture
beads for polysome isolation is presented in
Supplementary Figure S1.
Translationally regulated genes can be captured
by aﬃnity capture beads
To determine the feasibility of isolating the hsp70-
associated translational complex, we utilized an in vitro
rabbit reticulocyte lysate coupled transcription/translation
system with an expression construct pGEM-pcHTS-1 pro-
viding expression of full-length TS mRNA (15). Our
results clearly indicate that we can immunoprecipitate
the TS translation complex with hsp70 antibody aﬃnity
capture beads as shown in Figure 2. The absence of TS
protein with control beads coupled to an anti-tubulin
antibody (lane 1) indicates the speciﬁcity of our hsp70
antibody aﬃnity capture beads (Figure 2A). We can
detect the presence of newly synthesized TS protein in
the isolated complex using western immunoblot analysis
(lane 2) (Figure 2A). The associated TS mRNA template
was also detected using real-time qRT-PCR analysis
(lane 2, Figure 2B).
Translationally regulated genes can be captured by
aﬃnity capture beads from HCT-116 colon cancer cells
To directly demonstrate that we are capturing polysomes
with aﬃnity capture beads, HCT-16 colon cancer cells was
incubated with 400mM puromycin, a drug that triggers
premature polypeptide termination and polysome
disassembly. HCT-116 colon cancer cells treated with
400-mM puromycin reduced the total RNA levels
associated with the hsp70 RNP complex compared to
control cells (Supplementary Figure S2A). Real-time
qRT-PCR analysis further revealed decreased level of
translational initiation factor eIF4E with puromycin treat-
ment (Supplementary Figure S2B). To further demon-
strate directly in vivo that we can isolate translationally
active mRNA complexes associated with hsp70 proteins,
we utilized the HCT-116 human colon cancer cell line
model with or without 5-FU treatment. We used two
genes, p53 and TS, previously shown to be translationally
regulated to monitor the isolation and quantiﬁcation
process (1,18). We were able to isolate actively translating
mRNAs with our aﬃnity capture approach as determined
by both the presence of p53 and TS mRNAs. As shown in
Figure 3A, the steady-state total cellular mRNA levels of
TS and p53 was unchanged after 5-FU exposure (n=3,
P<0.05) (15,18). By contrast, both TS and p53 mRNA
transcripts isolated from the polysome complex were
elevated by 5-FU treatment (n=3, P<0.01, CV<5%)
(Figure 3B). These results were supported by the corre-
sponding increases of TS and p53 proteins determined
by western blot analysis (Figure 3C).
We have previously reported that as an RNA-binding
protein TS can suppress the expression of p53 at the
translational level by direct interaction with p53 mRNA
(18,19). To further demonstrate that we can capture
endogenous translationally regulated events independent
of 5-FU treatment, we used previously developed colon
cancer cell lines HCT-C (TS–) and HCT-C (TS+) to
show that the suppression of p53 mRNA translation by
RNA-binding protein TS can be delineated with the
hsp-70 aﬃnity bead capture approach. Our experimental
results indicated that the decreased p53 protein expression
due to translational arrest by the TS protein can be
revealed by hsp-70 antibody aﬃnity capture beads
(Supplementary Figure S3A, lane 2). The reduced level
of actively translated p53 mRNA in the hsp-70 nascent
translation complex was consistent with the reduction of
p53 protein levels while total levels of p53 mRNA were
unchanged (Supplementary Figure S3B).
Expression analysis of 5-FU responsive translationally
active genes isolated from polysome complexes
in HCT-116 cells
After we conﬁrmed and optimized our isolation pro-
cess, we sought to determine novel post-transcriptionally
regulated genes aﬀected by 5-FU treatment. To do so, the
mRNAs isolated with the antibody aﬃnity capture beads
were used to quantify mRNA expression using human
Codelink
TM whole-genome microarray analysis. We
identiﬁed over 500 genes that were diﬀerentially regulated
by 5-FU treatment, including our positive control genes
Hsp70
AUG Stop
polyA-3´ 5´
AUG Stop
polyA-3´ 5´
Reverse transcription
Oligo dT-T7
AUG Stop
polyA-3´ 5´
cDNA
Gene Expression analysis via qPCR and Microarray
Figure 1. Schematic diagram of TrIP–Chip approach. Aﬃnity beads
with covalently attached anti-Hsp70 antibodies are used to
immunoprecipitate a cross-linked complex composed of Hsp70,
nascent peptides, polysomes and the actively translating mRNAs. The
mRNAs are used to conduct qPCR or converted to a labeled cRNA in
a two-step reaction, and hybridized to whole genome microarrays for
analysis. If translation is not taking place, there are no nascent peptides
with which Hsp70 can associate.
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(complete list in Supplementary Table S1). Many genes
involved in translational control were upregulated.
This includes genes such as TS (15), p53 (18), PP2A
(20), hsp70 (25), thymidine kinase (26) and ornithine
decarboxylase (27), which have previously been shown
to be regulated by 5-FU at the post-transcriptional or
translational level. We also conﬁrmed the micro-
array expression analysis data using real-time qRT-PCR
analysis with 10 randomly selected genes. Our results
showed that the expression levels of selected genes
quantiﬁed by microarray analysis are in good
correlation (P<0.02) with real-time qRT-PCR results
(Table 2). The downregulated genes include ATG5,
Claudin18, FGFR4, GPCR162, KIF21A and PDE1C,
and some of these genes (ATG5, Claudin18 and
FGFR4) are reported to be associated with
chemoresistance (28–30).
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Figure 3. Real-time qRT-PCR analysis of TS and p53 mRNA expression from total RNA isolated from control and 5-FU-treated HCT116 cells
(n=3, P<0.05) (A); Real-time qRT-PCR analysis of TS, p53 and a-tubulin mRNA expression from hsp70/hsc70 antibody aﬃnity capture bead
isolated RNAs from control and 5-FU-treated HCT116 cells (n=3, P<0.05) (B); Western immunoblot analysis of the expression of TS and p53
proteins isolated using hsp70/hsc70s antibody aﬃnity capture beads (lane 1, control; lane 2, treated with 5-FU) (C). The lower panel shows the
quantiﬁed protein expression levels for TS and p53.
AUG
Stop
polyA-3´ 5´
TS Expression Plasmid
+
Rabbit reticulocyte lysate 
in vitro transcription/
translation system Nascent TS polypeptide hsp70
Hsp 70Ab capture beads
60S
40S
TS
kDa  1              2
35
0
5
10
15
20
25
R
e
l
a
t
i
v
e
Q
u
a
n
t
i
f
i
c
a
t
i
o
n
1                      2
B A
Figure 2. Western immunoblot analysis of in vitro translated TS protein expression isolated using hsp70/hsc70 antibody aﬃnity capture beads (lane
2); unrelated a-tubulin antibody beads were used as negative control (lane 1) (A). Real-time qRT-PCR analysis of in vitro transcribed TS mRNA
expression (lane 1, control; lane 2, TS mRNA) (B).
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mRNA levels are being measured in these hybridization
assays, increased mRNA abundance in this polysome
fraction would be expected to indicate increased levels of
translation. However, some of which will also reﬂect in the
levels of increased transcription or mRNA turn over.
Changes in transcription would only be revealed when
total steady-state mRNA abundance is measured if there
is no translation control. We performed GO analysis using
the DAVID Bioinformatics Resource to discover impor-
tant gene pathways involved in post-transcriptional
regulation (http://david.abcc.ncifcrf.gov/) (31) (Figure 4).
DAVID Gene Functional Classiﬁcation algorithm allows
us to condense our gene list into organized classes based
Table 1. Post-transcriptionally regulated genes mediated by 5-FU treatment in HCT116 colon cancer cells isolated by TrIP–Chip analysis (partial
list)
Gene ID Fold change Gene name
NM_001416 4.515 Eukaryotic translation initiation factor 4A, isoform 1 (EIF4A1)
NM_022170 9.517 Eukaryotic translation initiation factor 4H (EIF4H), transcript variant 1
NM_006597 11.35 Heat-shock 70-kDa protein 8 (HSPA8), transcript variant 1
NM_182640 4.873 Mitochondrial ribosomal protein S9 (MRPS9), nuclear gene encoding mitochondrial protein
NM_020360 5.118 Phospholipid scramblase 3 (PLSCR3)
NM_000937 22.14 Polymerase (RNA) II (DNA directed) polypeptide A, 220kDa (POLR2A)
NM_006232 6.268 Polymerase (RNA) II (DNA directed) polypeptide H (POLR2H)
NM_032959 5.668 DNA-directed RNA polymerase II polypeptide J-related gene (POLR2J2)
NM_021128 6.834 Polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa (POLR2L)
NM_005837 6.522 Processing of precursor 7, ribonuclease P subunit (S. cerevisiae) (POP7)
NM_021129 18.13 Pyrophosphatase (inorganic) 1 (PPA1)
NM_177983 4.641 Protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma isoform (PPM1G)
NM_138689 7.384 Protein phosphatase 1, regulatory (inhibitor) subunit 14B (PPP1R14B)
NM_024607 11.47 Protein phosphatase 1, regulatory (inhibitor) subunit 3B (PPP1R3B)
NM_138558 8.723 Protein phosphatase 1, regulatory (inhibitor) subunit 8 (PPP1R8), transcript variant 2
NM_002715 5.813 Protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform (PPP2CA)
NM_001009552 10.09 Protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform (PPP2CB), transcript variant 2
NM_033625 59.35 Ribosomal protein L34 (RPL34)
NM_000996 21.23 Ribosomal protein L35a (RPL35A)
NM_015414 5.287 Ribosomal protein L36 (RPL36)
NM_021029 17.53 Ribosomal protein L36a (RPL36A)
NM_000998 8.972 Ribosomal protein L37a (RPL37A)
NM_000999 100.7 Ribosomal protein L38 (RPL38)
NM_001000 7.078 Ribosomal protein L39 (RPL39)
NM_000972 10.35 Ribosomal protein L7a (RPL7A)
NM_001030 9.202 Ribosomal protein S27 (metallopanstimulin 1) (RPS27)
NM_001032 22.91 Ribosomal protein S29 (RPS29), transcript variant 1
NM_001005 5.221 Ribosomal protein S3 (RPS3)
NM_001010 136.6 Ribosomal protein S6 (RPS6)
NM_001011 21.93 Ribosomal protein S7 (RPS7)
NM_001033 4.609 Ribonucleotide reductase M1 polypeptide (RRM1)
NM_001034 30.43 Ribonucleotide reductase M2 polypeptide (RRM2)
NM_006819 7.226 Stress-induced phosphoprotein 1 (Hsp70/Hsp90-organizing protein) (STIP1)
NM_003258 48.01 Thymidine kinase 1, soluble (TK1)
NM_016399 16.27 TP53 regulated inhibitor of apoptosis 1 (TRIAP1)
NM_001071 4.999 Thymidylate synthetase (TYMS)
NM_003400 5.32 Exportin 1 (CRM1 homolog, yeast) (XPO1)
NM_002789 18.14 Proteasome (prosome, macropain) subunit, alpha type, 4 (PSMA4)
NM_002791 9.663 Proteasome (prosome, macropain) subunit, alpha type, 6 (PSMA6)
NM_002793 36.45 Proteasome (prosome, macropain) subunit, beta type, 1 (PSMB1)
NM_002802 5.809 Proteasome (prosome, macropain) 26S subunit, ATPase, 1 (PSMC1)
NM_005805 4.907 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 (PSMD14)
NM_007273 7.634 Prohibitin 2 (PHB2)
NM_00546 5.75 Tumor protein p53 (TP53)
NM_004152 26.8 Ornithine decarboxylase antizyme 1 (OAZ1)
NM_004394 4.549 Death-associated protein (DAP)
Table 2. Comparison of microarray and qRT-PCR results (two sided
Pearson correlation analysis P=0.02)
Gene name Microarray
(fold)
qRT-PCR
(fold)
RRM1 4.60 5.80
OAZ1 26.1 11.5
TK1 48.2 8.90
EIF4A 4.50 5.50
PSMC1 5.80 7.50
RPS3 5.20 3.85
STIP1 7.22 5.60
HSPA5 7.29 6.14
STX3 7.21 5.78
NEDD8 4.72 6.30
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based on their cellular and molecular functions, which
help us to identify functional related genes presented as
a fuzzy heat map graphic view (Figure 4A). A zoomed-in
view of cluster one is shown in Figure 4B. Most of the
genes in cluster one are associated with protein
translational initiation process. The fuzziness capability
is a unique feature to maximally preserve biological
patterns and to discover ﬁne diﬀerences for a given gene.
More than 20 clusters were represented with unique func-
tions, such as protein synthesis, cell cycle control and
RNA binding. The distribution of major classiﬁed gene
clusters was presented as a pie chart (Figure 4C).
Conﬁrmation of post-transcriptionally regulated genes
To conﬁrm directly that some of the newly identiﬁed genes
were indeed regulated post-transcriptionally, we measured
protein expression by western blot and quantiﬁed mRNA
by real-time qRT-PCR analysis. The results indicated that
proteins such as PP2A was regulated most likely at the
translational level (Figure 5A), as the total mRNA level
of PP2A was not changed, whereas the polysome bound
PP2A mRNA level was increased (Figure 5B).
DISCUSSION
We have described here a novel approach to systematically
study post-transcriptionally regulated genes from as few
as 500 cells with hsp70/hsc70 antibody aﬃnity capture
beads. The results obtained from puromycin treatment
further conﬁrmed that the RNAs captured by hsp70/
hsc70 antibody aﬃnity capture beads are indeed
associated with active translation events (Supplementary
Figure S4). In this study, we have developed a method to
capture mRNAs engaged in nascent translation, and we
used this approach to identify a number of genes poten-
tially post-transcriptionally regulated by 5-FU treatment
when combined with a parallel expression analysis of total
steady-state mRNA transcripts (6). We expect that some
of these transcripts will be useful in understanding 5-FU
related chemosensitivity. Many of these genes would have
been missed if we had just proﬁled total RNAs, since
translational control does not alter steady-state mRNA
levels but rather translational eﬃciency. The minimal
overlap of our gene list with previously reported genes
aﬀected by 5-FU treatment in analyzing steady-state
mRNAs suggests that we predominantly capture and
reﬂect changes of mRNAs involved in nascent translation
(32). It is not surprising to see there are a number of
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Figure 4. GO analysis was performed using the DAVID bioinformatics suite. The DAVID Gene Functional Classiﬁcation algorithm allows us to
condense our gene list into organized classes based on cellular functions. The genes are grouped and clustered based on their cellular and molecular
functions, which helps to identify functionally related genes, presented as a fuzzy heat map graphic view. The annotation terms are ordered based on
the enrichment scores associated with the groups. Green represents a positive association between the gene terms; conversely, black represents an
unknown relationship. The scattered pattern indicates functional diﬀerences. More than 20 clusters were represented with unique functions such as
protein synthesis, cell cycle control and RNA binding (A). A zoomed-in view of the upper left cluster representing genes involved in translational
initiation (B). The distribution of each set of classiﬁed genes is presented as a pie chart (C).
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exposure. GO analysis by DAVID provides an overview
of genes associated with diﬀerent biological processes
(Figure 4). There are over 40% of genes that are related
to protein biosynthesis (ribosomal proteins, translational
initiation factors andRNA-binding proteins). Other genes
involved are protein chaperons, RNA processing proteins,
cell cycle control genes and phosphoproteins. Known
drug-resistance-related genes such as calmodulin, EIFs
related to mTOR pathway, and proteasome 26S subunit
were all upregulated. Our results clearly showed that
translational control played a major role in response to
5-FU treatment.
We are able to monitor the polysome isolation process
using known translationally regulated genes, such as TS
and p53, to ensure that the isolation process is robust and
reproducible (Figure3B and C). We also noticed that the
TS and p53 bands represent mostly full-length protein as
analyzed by western immunoblot. This could be because
the antibodies only recognize full-length proteins and not
the shorter polypeptides. We randomly selected 10 genes
from the gene expression array analysis to conﬁrm the
results by real-time qRT-PCR analysis (Table 2). Our
results showed that the two sets of data are well
correlated. We also demonstrated that our new
approach can capture endogenous translationally
regulated genes independent of drug response
(Supplementary Figure S3). Furthermore, the large
degree of overlap with expression proﬁles obtained using
the high-density sucrose gradient ultracentrifugation
approach suggests that we have indeed captured most of
the mRNAs in the polysomal translational complex
(Supplementary Figure S4 and Supplementary Data).
The non-overlapping genes may be accounted for by
biases attendant in each of the approaches, neither of
which may be able to recapitulate completely the reper-
toire of polysome-associated mRNAs. The amount of
hsp70 proteins in the polysome complex are enriched
(Supplementary Figure S4), which is highly consistent
with previous studies indicating that hsp70s are one of
the major family of chaperones involved in translation;
other chaperone proteins (e.g. hsp40 and hsp90) are also
part of the hsp70 complex (9,11,33).
The new approach we have developed here adds a key
tool necessary for investigating post-transcriptionally
regulated genes from a small number of cells. The combi-
nation of this methodology with gene expression
analysis represents a powerful approach for understanding
genes translationally regulated by RNA-binding pro-
teins or miRNAs in a variety of important biological pro-
cesses. The current limit of isolating polysomes for
expression analysis was the RNA quantity requirement
of the expression platform. By coupling our approach
with the digital expression analysis oﬀered by the next
generation DNA sequencing, we should be able to system-
atically investigate translational control from single cell in
the future.
This study establishes the principle for integrating
translational control by isolating actively translated
mRNAs associated with protein chaperones such as
hsp70. The data we obtained in this study indicated that
the capture approach using hsp70s isolated most of the
mRNAs involved in nascent translation since hsp70s are
major contributors to eﬃcient protein folding globally
(34). We are aware that there are other types of protein
chaperones such as hsp40 and hsp90. However, as both
hsp40 and hsp90 are part of the hsp70 molecular chaper-
one complex associated with nascent polypeptides (33), we
believe that it is possible to capture most of the
translational complex using the hsp70 antibody aﬃnity
beads. Nonetheless, the method we developed here may
be further improved by combining antibody capture beads
consist of all major protein chaperones.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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Figure 5. Western immunoblot analysis of PP2A protein expression isolated using hsp70/hsc70 antibody aﬃnity capture beads from control and
5-FU-treated HCT116 colon cancer cells (lane 1, control; lane 2, plus 5-FU). Quantiﬁcation of the protein levels for PP2A is provided in the lower
panel (A). Real-time qRT-PCR analysis of total PP2A mRNA and polysome associated mRNA levels in control and 5-FU-treated HCT-116 colon
cancer cells (B).
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